⌘K

Home/Filings/4/0001209191-22-035284

4//SEC Filing

Girao Tiago 4

Accession 0001209191-22-035284

CIK 0001785345other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 8:53 AM ET

Size

5.2 KB

Accession

0001209191-22-035284

Insider Transaction Report

Form 4

Period: 2022-06-07

Landos Biopharma, Inc.LABP

Director

Transactions

Award
Stock Option (right to buy)
2022-06-07+18,000→ 18,000 total
Exercise: $0.91Exp: 2032-06-06→ Common Stock (18,000 underlying)

Footnotes (1)

[F1]The shares subject to this option will vest and become exercisable on June 7, 2023, subject to the Reporting Person providing continuous service through such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1

filerCIK 0001618670

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 8:53 AM ET
Size: 5.2 KB

View on SEC.gov